Results 131 to 140 of about 2,506,502 (302)

Japan (South) [cartographic material] : special strategic map /

open access: yes, 1943
Map of southern Japan showing transportation, water features and populated places. Relief shown by hachures and spot heights.; "6/43 N/P".; Also available online http://nla.gov.au/nla.map ...
United States. Army Map Service.
core  

Truk Islands: special strategic map.

open access: yes, 1962
Scale 1:1,000,000 ; Lambert conformal conic projection, standard parallels 7° and 20°, (E 148°--E 154°/N 10°--6°). 1 map : color ; 46 x 68 cm. Edition 1-AMS. Compiled by the Army Map Service, February 1943.
United States. Army Map Service.
core   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Sulu Archipelago 1:25,000 [cartographic material] /

open access: yes, 1944
1st ed. (AMS 1). Topographic maps of the Sulu Archipelago, Philippines. Relief shown by soundings, spot heights, contours, and form lines where shown at approximately 100 foot intervals, heights and depths in feet.; Standard map series designation ...
United States. Army Map Service.
core  

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

open access: yesMolecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang   +9 more
wiley   +1 more source

Latent diffusion can map beam loss to two-dimensional phase-space projections

open access: yesPhysical Review Accelerators and Beams
Beam loss monitors (BLMs) and beam current monitors (BCMs) are ubiquitous at particle accelerators around the world. These simple devices provide noninvasive high-level beam measurements but give no insight into the detailed 6D (x,y,z,p_{x},p_{y},p_{z ...
Alexander Scheinker, Alan Williams
doaj   +1 more source

CEACAM1 participation in breast cancer progression

open access: yesMolecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin   +3 more
wiley   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

open access: yesMolecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas   +16 more
wiley   +1 more source

Calculation and Visualization of Flexion and Skewness

open access: yesKartografija i Geoinformacije, 2018
A recent study on map projections expanded two new measures of distortion, namely flexion and skewness. However, it introduced them only for the unit sphere.
Krisztián Kerkovits
doaj  

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

open access: yesMolecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy